MEDIGENE AG
Patent Owner
Stats
- 23 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Mar 08, 2018 most recent publication
Details
- 23 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 804 Total Citation Count
- May 05, 1999 Earliest Filing
- 52 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9821043 Anti-HER2 vaccine based upon AAV derived multimeric structuresSep 14, 12Nov 21, 17[A61K, C12P, C12N, C07K]
9464119 Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3Mar 04, 10Oct 11, 16[A61K, C12N, C07K]
9260521 Treatment of tumors using specific anti-L1 antibodyOct 03, 13Feb 16, 16[A61K, C12P, G01N, A61N, C07K]
7968340 Structural protein of adeno-associated virus with modified antigenicity, its production and its useJun 15, 09Jun 28, 11[C12N]
7932253 Immunomodulating oxopyrrazolocinnolines as CD80 inhibitorsAug 09, 04Apr 26, 11[A61K, C07D, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8092807 Modified leukocyte Ig-like receptor family members (LIRs) with increased affinity for class 1 MHC and their uses in modulating T-cell activationExpiredMay 19, 06Jan 10, 12[A61K]
2011/0212,072 Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial DysfunctionAbandonedApr 19, 11Sep 01, 11[A61K, C12Q, C07D, C07C, G01N, A61P]
2011/0052,617 AAV SCLEROPROTEIN, PRODUCTION AND USE THEREOFAbandonedDec 01, 09Mar 03, 11[A61K, C07H, C12N]
2011/0002,851 Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory DiseasesAbandonedOct 31, 07Jan 06, 11[A61K, A61P]
2010/0297,177 MUTATED PARVOVIRUS STRUCTURAL PROTEINS AS VACCINESAbandonedJun 02, 08Nov 25, 10[A61K, C07H, C12P, C12N, A61P, C40B, C07K]
2010/0297,214 PERCOLATIVE DRYING FOR THE PREPARATION OF PARTICLESAbandonedOct 26, 07Nov 25, 10[A61K, F26B]
2010/0203,083 MUTATED STRUCTURAL PROTEIN OF A PARVOVIRUSAbandonedJun 02, 08Aug 12, 10[A61K, C07H, C12N, A61P, C07K]
2010/0178,243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier systemAbandonedDec 22, 09Jul 15, 10[A61K, A61P]
2010/0105,123 SCLEROPROTEIN OF AN ADENO-ASSOCIATED VIRUS WITH MODIFIED CHROMATOGRAPHIC PROPERTIES, THE PRODUCTION THEREOF AND USE OF THE SAMEAbandonedSep 24, 07Apr 29, 10[C12N]
2010/0034,749 Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular DiseasesAbandonedJul 09, 07Feb 11, 10[A61K, A61P]
2010/0034,796 Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunctionAbandonedJun 29, 09Feb 11, 10[A61K, C12Q, A61P]
2009/0317,456 USE OF ONCOLYTIC VIRUSES AND ANTIANGIOGENIC AGENTS IN THE TREATMENT OF CANCERAbandonedOct 15, 07Dec 24, 09[A61K, A61P]
2009/0232,731 Cationic Liposomal Preparations for the Treatment of Rheumatoid ArthritisAbandonedMay 18, 07Sep 17, 09[A61K]
7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its useExpiredJul 23, 07Jul 07, 09[C12N]
2007/0238,684 AAV scleroprotein, production and use thereofAbandonedDec 28, 06Oct 11, 07[A61K, C07H, C12P, C12N, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.